BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chew KW, Bhattacharya D. Virologic and immunologic aspects of HIV-hepatitis C virus coinfection. AIDS 2016;30:2395-404. [PMID: 27427873 DOI: 10.1097/QAD.0000000000001203] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Mulherkar TH, Gómez DJ, Sandel G, Jain P. Co-Infection and Cancer: Host–Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses. Viruses 2022;14:2037. [DOI: 10.3390/v14092037] [Reference Citation Analysis]
2 Shirley K, Loftis JM. A spotlight on HCV and SARS-CoV-2 co-infection and brain function. Pharmacol Biochem Behav 2022;:173403. [PMID: 35561837 DOI: 10.1016/j.pbb.2022.173403] [Reference Citation Analysis]
3 Morsica G, Galli L, Messina E, Castagna A, Bagaglio S, Salpietro S, Liviana DT, Uberti-Foppa C, Hasson H. Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV. PLoS One 2022;17:e0262917. [PMID: 35113890 DOI: 10.1371/journal.pone.0262917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gobran ST, Ancuta P, Shoukry NH. A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection. Front Immunol 2021;12:726419. [PMID: 34456931 DOI: 10.3389/fimmu.2021.726419] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Kwofie TB, Adigbli D, Osei-Yeboah J, Ativi E, Lokpo SY. Hepatitis B and C infections in HIV-1 patients on combination antiretroviral therapy (cART) in Ghana: implications for immunologic recovery, clinical response to treatment, and hepatotoxicity. Heliyon 2021;7:e07172. [PMID: 34141932 DOI: 10.1016/j.heliyon.2021.e07172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Bulfoni M, Pravisani R, Dalla E, Cesselli D, Hidaka M, Di Loreto C, Eguchi S, Baccarani U. miRNA expression profiles in liver grafts of HCV and HIV/HCV-infected recipients, 6 months after liver transplantation. J Med Virol 2021;93:4992-5000. [PMID: 33818800 DOI: 10.1002/jmv.26999] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Isaguliants M, Bayurova E, Avdoshina D, Kondrashova A, Chiodi F, Palefsky JM. Oncogenic Effects of HIV-1 Proteins, Mechanisms Behind. Cancers (Basel) 2021;13:305. [PMID: 33467638 DOI: 10.3390/cancers13020305] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
8 Roca B; Spanish VACH Cohort Group. Factors Associated with Nonsuppression of HIV Infection in the Spanish VACH Cohort. AIDS Res Hum Retroviruses 2020;36:927-32. [PMID: 32772710 DOI: 10.1089/AID.2020.0016] [Reference Citation Analysis]
9 Eid J, Mougel M, Socol M. Advances in Continuous Microfluidics-Based Technologies for the Study of HIV Infection. Viruses 2020;12:E982. [PMID: 32899657 DOI: 10.3390/v12090982] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
10 Pereson MJ, Martínez AP, Isaac K, Laham G, Ridruejo E, Garcia GH, Flichman DM, Di Lello FA. Prevalence of Hepatitis B, Hepatitis C and HIV infection among patients undergoing hemodialysis in Argentina.. [DOI: 10.1101/2020.08.04.20168385] [Reference Citation Analysis]
11 Koļesova O, Madelāne M, Ekšteina I, Koļesovs A, Krūmiņa A, Vīksna L. The Level of Cytokeratin 18 in Patients with HIV and Viral Hepatitis C Co-Infection in Latvia. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2020;74:94-99. [DOI: 10.2478/prolas-2020-0015] [Reference Citation Analysis]
12 Jia XC, Xia ZH, Shi N, Wang YP, Luo ZX, Yang YL, Shi XZ. The factors associated with natural disease progression from HIV to AIDS in the absence of ART, a propensity score matching analysis. Epidemiol Infect 2020;148:e57. [PMID: 32089142 DOI: 10.1017/S0950268820000540] [Reference Citation Analysis]
13 Corma-Gómez A, Morano L, Téllez F, Rivero-Juárez A, Real LM, Alados JC, Ríos-Villegas MJ, Vera-Méndez FJ, Muñoz RP, Geijo P, Macías J, Pineda JA; RIS-HEP13 and GEHEP 011 study groups. HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals. AIDS 2019;33:1167-74. [PMID: 30845068 DOI: 10.1097/QAD.0000000000002186] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
14 Meissner EG. Update in HIV-hepatitis C virus coinfection in the direct acting antiviral era. Curr Opin Gastroenterol 2017;33:120-7. [PMID: 28234770 DOI: 10.1097/MOG.0000000000000347] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]